Run,Assay Type,AssemblyName,AvgSpotLen,BioProject,BioSample,Cell_type,Center Name,Consent,DATASTORE filetype,DATASTORE provider,DATASTORE region,Experiment,GEO_Accession,Instrument,LibraryLayout,LibrarySelection,LibrarySource,MBases,MBytes,Organism,Platform,ReleaseDate,sample_acc,Sample Name,source_name,SRA Study,treatment
SRR10238697,RNA-Seq,GCA_000001405.13,197,PRJNA576221,SAMN12982853,skin fibroblast,GEO,public,"bam,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",SRX6957877,GSM4110074,Illumina HiSeq 2500,SINGLE,cDNA,TRANSCRIPTOMIC,3006,646,Homo sapiens,ILLUMINA,2019-10-09T00:00:00Z,SRS5484759,GSM4110074,HCA2 (MJ90),SRP224616,low passage
SRR10238698,RNA-Seq,GCA_000001405.13,197,PRJNA576221,SAMN12982852,skin fibroblast,GEO,public,"bam,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",SRX6957878,GSM4110075,Illumina HiSeq 2500,SINGLE,cDNA,TRANSCRIPTOMIC,4102,868,Homo sapiens,ILLUMINA,2019-10-09T00:00:00Z,SRS5484760,GSM4110075,HCA2 (MJ90),SRP224616,21 days after doxorubicin treatment
SRR10238699,RNA-Seq,GCA_000001405.13,197,PRJNA576221,SAMN12982856,skin fibroblast,GEO,public,"bam,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",SRX6957879,GSM4110076,Illumina HiSeq 2500,SINGLE,cDNA,TRANSCRIPTOMIC,3482,773,Homo sapiens,ILLUMINA,2019-10-09T00:00:00Z,SRS5484761,GSM4110076,HCA2 (MJ90),SRP224616,21 days after turt-butyl hydroperoxide treatment
SRR10238700,RNA-Seq,GCA_000001405.13,197,PRJNA576221,SAMN12982855,skin fibroblast,GEO,public,"bam,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",SRX6957880,GSM4110077,Illumina HiSeq 2500,SINGLE,cDNA,TRANSCRIPTOMIC,3663,792,Homo sapiens,ILLUMINA,2019-10-09T00:00:00Z,SRS5484762,GSM4110077,HCA2 (MJ90),SRP224616,high passage
SRR10238701,RNA-Seq,GCA_000001405.13,197,PRJNA576221,SAMN12982854,skin fibroblast,GEO,public,"bam,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",SRX6957881,GSM4110078,Illumina HiSeq 2500,SINGLE,cDNA,TRANSCRIPTOMIC,3435,734,Homo sapiens,ILLUMINA,2019-10-09T00:00:00Z,SRS5484763,GSM4110078,HCA2 (MJ90),SRP224616,21 days after RO3306+nutlin3a treatment
